首页> 外国专利> COMPOSITIONS FOR TREATEMENT OF HEMORRHAGING WITH ACTIVATED FACTOR VIIA IN COMBINATION WITH FIBRINOGEN

COMPOSITIONS FOR TREATEMENT OF HEMORRHAGING WITH ACTIVATED FACTOR VIIA IN COMBINATION WITH FIBRINOGEN

机译:活化因子VIIa与纤维蛋白原联合治疗出血的组合物

摘要

The combination of recombinant factor VIIa and fibrinogen is effective in treatment for bleeding where direct pressure, tourniquets, indirect pressure, surgical ligation, bandaging, and transfusion of blood or plasma products are typically used. The combination of factor VIIa and fibrinogen is administered intravenously, either sequentially or simultaneously. The compositions may be safely circulated in the blood vessels to sites of injury. This is effective for single or multiple external or internal wounds.
机译:重组因子VIIa和纤维蛋白原的组合可有效治疗出血,通常使用直接加压,止血带,间接加压,外科结扎,包扎和输血或血浆产品。因子VIIa和纤维蛋白原的组合可以依次或同时静脉内给药。所述组合物可在血管中安全循环至损伤部位。这对于单个或多个外部或内部伤口有效。

著录项

  • 公开/公告号EP1351705B1

    专利类型

  • 公开/公告日2009-08-12

    原文格式PDF

  • 申请/专利权人 U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND;

    申请/专利号EP20010901920

  • 发明设计人 HESS JOHN R.;

    申请日2001-01-10

  • 分类号A61K38/36;A61K38/48;A61P7/04;

  • 国家 EP

  • 入库时间 2022-08-21 19:19:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号